Both Semaglutide and copyright are glucagon-like peptide-1 a group of therapies called GLP-1 receptor for agonists . These innovative medicines operate by resembling the body's inherent hormone , GLP-One , to help decrease glucose levels and encourage a decrease in weight. This common mechanism of function explains why these drugs are often evaluat